cimb-logo

Journal Browser

Journal Browser

Natural Products in Health and Disease: Mechanisms, Therapeutic Applications, and Emerging Challenges

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Biochemistry, Molecular and Cellular Biology".

Deadline for manuscript submissions: 31 May 2026 | Viewed by 775

Special Issue Editor


E-Mail Website
Guest Editor
Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 1342 Seong-namdae-ro, Sujeong-gu, Seongnam-si 13120, Republic of Korea
Interests: herbal medicine; bioinformatics; network pharmacology; statistics; Korean medicine; systematic review; meta-analysis; integrative medicine; drug discovery

Special Issue Information

Dear Colleagues,

Natural products, rooted in traditional medicine, are being integrated with modern science to offer new therapeutic strategies for chronic and intractable diseases. Moving beyond their empirical use in the past, elucidating the multi-component-multi-target action mechanisms of natural products and establishing scientific evidence have now emerged as critical challenges. Recent studies, in particular, have revealed that when administered orally, natural products influence systemic health by interacting with the gut microbiota through various pathways, such as the gut-brain, gut-liver and gut-heart axes. This deepens our understanding of their complex and sophisticated therapeutic potential.

Natural products have been shown to improve various diseases, including neurological disorders, metabolic syndrome, and chronic liver disease, by restoring the balance of the gut microbiota, strengthening barrier function and regulating inflammation and oxidative stress. These findings suggest that natural products could serve as innovative therapeutic strategies that address the fundamental causes of disease in multiple ways, going beyond mere symptom relief.

This Special Issue, ‘Natural Products in Health and Disease: Mechanisms, Therapeutic Applications, and Emerging Challenges,’ aims to explore the scientific value of natural products based on these latest research trends. We welcome innovative research that clarifies the therapeutic mechanisms of natural products, enhances their clinical applicability and ensures their safety.

We are particularly seeking original manuscripts related to the following topics:

  1. Studies establishing preclinical evidence for natural products against target diseases using innovative in vivo, in vitro and ex vivo models
  2. Research that precisely analyzes the action targets and pathways of natural products using diverse bioinformatics technologies, with subsequent experimental validation
  3. Studies comparing the safety and efficacy of natural product-derived crude extracts versus their key active components
  4. Research applying network toxicology techniques to predict toxicity and experimentally evaluate proposed mitigation strategies
  5. Studies demonstrating the superiority of natural products over synthetic single-component-single-target drugs for specific indications, both in efficacy and mechanism
  6. Research exploring the advantages of natural products' inherent multi-target regulatory actions in biological systems

* Please note: All manuscripts must include experimental validation conducted in a wet lab. 

We anticipate that this Special Issue will broaden the horizons of natural products research and serve as a key platform for academic exchange, ultimately contributing to the advancement of human health.

Prof. Dr. Hee-Geun Jo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • herbal medicine
  • network pharmacology
  • multi-omics
  • microbiome
  • synergistic effects
  • multi-target
  • drug discovery
  • natural products

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 2422 KB  
Article
Multiscale Interactome–Guided Prioritization of Candidate Herbs and Active Compounds for Hepatic Cirrhosis Using a Biased Random Walk Algorithm
by Jun-ho Lee, Seon-Been Bak, Won-Yung Lee and Yun-Kyung Kim
Curr. Issues Mol. Biol. 2026, 48(3), 277; https://doi.org/10.3390/cimb48030277 - 4 Mar 2026
Viewed by 475
Abstract
Hepatic cirrhosis is a progressive chronic liver disease driven by sustained inflammation, cell death, and tissue remodeling, and effective disease-modifying options remain limited. Here, we applied a multiscale interactome framework to prioritize candidate herbs and active compounds for hepatic cirrhosis. Herb–compound associations were [...] Read more.
Hepatic cirrhosis is a progressive chronic liver disease driven by sustained inflammation, cell death, and tissue remodeling, and effective disease-modifying options remain limited. Here, we applied a multiscale interactome framework to prioritize candidate herbs and active compounds for hepatic cirrhosis. Herb–compound associations were collected from the OASIS database and mapped to experimentally supported compound–target interactions (DrugBank/TTD/STITCH), while cirrhosis-related proteins were curated from DisGeNET. Using a biased random-walk algorithm, we generated disease and herb/compound diffusion profiles on the multiscale network and ranked candidates by profile similarity and target overlap. Among the top-ranked herbs, Magnoliae Cortex, Notoginseng Radix et Rhizoma, Polygoni Cuspidati Rhizoma et Radix, and Capsici Fructus were supported by prior literature, whereas several high-ranking herbs lacked curated evidence and were highlighted as underexplored candidates, including Saposhnikoviae Radix and Fritillariae Cirrhosae Bulbus. Enrichment analyses indicated convergence on inflammatory and innate-immune pathways (TNF, Toll-like receptor, NF-κB) and apoptosis-related processes, with additional signals involving HIF-1 and PI3K–Akt pathways. Disease-focused subnetworks suggested mechanistic hypotheses for evidence-lacking compounds, including bergapten, oleic acid, and octadecanoic acid. Overall, we systematically prioritize herbal candidates and provides a mechanistic basis for follow-up validation in hepatic cirrhosis. Full article
Show Figures

Figure 1

Back to TopTop